HLB Genex, Inc. (KOSDAQ:187420)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,010.00
0.00 (0.00%)
Last updated: Aug 12, 2025

HLB Genex Company Description

HLB Genex, Inc. engages in the research and development, production, import/export, and sale of enzymes and fermentation products in South Korea and internationally.

Its industrial special enzyme products include lactase; catalase for use in semiconductor industry; and proteinase K for molecular diagnostics and genetic engineering experiments, as well as bio-health care ingredients comprise N-phytosphingosine and vitamin K2.

The company also develops drug candidates for wet and dry macular degeneration, inflammatory bowel disease, anticancer, oral mucositis, nonalcoholic steatohepatitis, diabetic macular edema, and dry eye indications.

The company was formerly known as GenoFocus, Inc. HLB Genex, Inc. was founded in 2000 and is based in Daejeon, South Korea.

HLB Genex, Inc.
CountrySouth Korea
Founded2000
IndustryIndustrial Organic Chemicals
Employees79
CEOEui-Joong Kim

Contact Details

Address:
65 Techno 1-ro
Daejeon, 34014
South Korea
Phone82 4 2862 4483
Websitehlbgenex.com

Stock Details

Ticker Symbol187420
ExchangeKOSDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyKRW
SIC Code2860

Key Executives

NamePosition
Eui-Joong KimChief Executive Officer